RBC Capital Maintains Sector Perform on WAVE Life Sciences, Raises Price Target to $7
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Luca Issi maintains a Sector Perform rating on WAVE Life Sciences (NASDAQ:WVE) and raises the price target from $5 to $7.
October 04, 2024 | 3:38 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
RBC Capital has increased the price target for WAVE Life Sciences from $5 to $7 while maintaining a Sector Perform rating. This suggests a positive outlook on the stock's potential performance.
The increase in price target from $5 to $7 by RBC Capital indicates a more optimistic view on WAVE Life Sciences' future performance. Maintaining a Sector Perform rating suggests that while the stock is expected to perform in line with the sector, the raised target price reflects potential upside.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100